Drugs / NaCl
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02162745 | Oct 2012 → May 2014 | bronchiolitis | IRCCS Burlo Garofolo | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NaCl | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02162745 ↗ |
| Known as | Hypertonic solution | “Drug: Hypertonic solution (NaCl 3%)” NCT02162745 ↗ |
| Route | Intranasal | “Single nasal irrigation with 1 ml of hypertonic solution (NaCl 3%) per each nostril” NCT02162745 ↗ |